Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Operating Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operating Profit (Excl OI) ₹1,269 Cr₹1,333 Cr₹1,025 Cr₹1,510 Cr₹1,302 Cr

What is the latest Operating Profit of GLAND PHARMA ?

The latest Operating Profit ratio of GLAND PHARMA is ₹1,269 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹1,269 Cr
Mar2025₹1,333 Cr
Mar2024₹1,025 Cr
Mar2023₹1,510 Cr
Mar2022₹1,302 Cr

How is Operating Profit of GLAND PHARMA Trending?

Years Operating Profit % Change
Mar2026 ₹1,269 Cr
-4.81
Mar2025 ₹1,333 Cr
30.09
Mar2024 ₹1,025 Cr
-32.14
Mar2023 ₹1,510 Cr
15.97
Mar2022 ₹1,302 Cr -

Compare Operating Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,988.6 Cr -0.5% 18.7% 53.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,675.0 Cr -3% -2.6% 21.3% Stock Analytics
DIVIS LABORATORIES ₹225,516.0 Cr -0.5% 17% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,190.0 Cr 0.6% 2.7% 35.5% Stock Analytics
CIPLA ₹115,523.0 Cr -2.2% 0.8% -2.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,493.4 Cr -1.1% -1.6% -0.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.5%

18.7%

53.6%

SENSEX

-1%

0.7%

-3.6%


You may also like the below Video Courses